Trials / Terminated
TerminatedNCT02163876
Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury
A Single-Blind, Randomized, Parallel Arm, Phase II Proof-of-Concept Study of the Safety and Efficacy of Human Central Nervous System Stem Cells (HuCNS-SC) Transplantation in Cervical Spinal Cord Injury
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- StemCells, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of human central nervous system stem cell transplantation into patients with traumatic injury in the cervical region of the spinal cord.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HuCNS-SC cells | surgery arm |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2014-06-16
- Last updated
- 2016-06-02
Locations
14 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02163876. Inclusion in this directory is not an endorsement.